Health Matters for Women Newsletter
Condom Use among Women of Reproductive Age (18-49 years) in Puerto Rico During the 2016 Zika Virus (ZIKV) Outbreak: Secondary Analysis of Data from a Cross-sectional, Population-based, Cell-phone Survey
Contraception is a medical countermeasure to reduce unintended pregnancy and ZIKV-associated birth defects. We estimated the prevalence of condom use and associated factors among women at risk for unintended pregnancy in Puerto Rico during the 2016 ZIKV outbreak.
Genital Microbiota of Women Using a 90 Day Tenofovir or Tenofovir and Levonorgestrel Intravaginal Ring in a Placebo Controlled Randomized Safety Trial in Kenya
Intravaginal rings (IVRs) are a safe, discreet and effective option for simultaneous delivery of contraception and antiretrovirals. In a phase-IIa trial, study authors investigated the influence of 90 days continuous-delivery tenofovir (TFV) IVRs with/without levonorgestrel (LNG) on the genital microbiota of Kenyan women. Microbiota shifts could influence genital health and ability of the female genital tract to protect against infections including sexually transmitted infections.
Human Papillomavirus Vaccine Beliefs and Practice Characteristics in Rural and Urban Adolescent Care Providers
The human papillomavirus (HPV) vaccine is recommended for all adolescents age 11-12 years. HPV vaccine coverage remains suboptimal in the United States though, particularly in rural areas. This study surveyed adolescent immunization providers in two Midwestern states to assess rural vs. urban differences in HPV vaccine resources, practices, and attitudes.
Interested in women’s health issues and research? Sign up to receive Health Matters for Women, a monthly e-newsletter that provides information on what is happening in women’s health around CDC and other agencies.
Enter your email below to sign up.
Enter your email to sign up for free to Health Matters for Women.